Peripheral Skeletal Muscle Impairment in Children After Treatment for Leukemia and Lymphoma.
Journal
Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928
Informations de publication
Date de publication:
01 11 2022
01 11 2022
Historique:
received:
08
07
2021
accepted:
16
11
2021
pubmed:
30
1
2022
medline:
1
11
2022
entrez:
29
1
2022
Statut:
ppublish
Résumé
Exercise intolerance is a common adverse effect of childhood cancer, contributing to impaired health and well-being. While reduced aerobic fitness has been attributed to central cardiovascular deficiencies, the involvement of peripheral musculature has not been investigated. We studied peripheral muscle function in children following cancer treatment using noninvasive phosphorus-31 magnetic resonance spectroscopy. Ten acute lymphoblastic leukemia (ALL) and 1 lymphoma patient 8 to 18 years of age who completed treatment 6 to 36 months prior and 11 healthy controls participated in the study. Phosphorus-31 magnetic resonance spectroscopy was used to characterize muscle bioenergetics at rest and following an in-magnet knee-extension exercise. Exercise capacity was evaluated using a submaximal graded treadmill test. Both analysis of variance and Cohen d were used as statistical methods to determine the statistical significance and magnitude of differences, respectively, on these parameters between the patient and control groups. The patients treated for ALL and lymphoma exhibited lower anaerobic function ( P =0.14, d =0.72), slower metabolic recovery ( P =0.08, d =0.93), and lower mechanical muscle power ( d =1.09) during exercise compared with healthy controls. Patients demonstrated lower estimated VO 2peak (41.61±5.97 vs. 47.71±9.99 mL/min/kg, P =0.11, d =0.76), lower minutes of physical activity (58.3±35.3 vs. 114.8±79.3 min, P =0.12, d =0.99) and higher minutes of inactivity (107.3±74.0 vs. 43.5±48.3 min, d =1.04, P <0.05). Children treated for ALL and lymphoma exhibit altered peripheral skeletal muscle metabolism during exercise. Both deconditioning and direct effects of chemotherapy likely contribute to exercise intolerance in this population.
Identifiants
pubmed: 35091514
doi: 10.1097/MPH.0000000000002397
pii: 00043426-202211000-00002
doi:
Substances chimiques
Phosphorus
27YLU75U4W
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
432-437Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Institute of Medicine (US), National Research Council (US), National Cancer Policy Board, Hewitt M, Weiner SL, Simone JV, eds. Childhood Cancer Survivorship. Washington, DC: National Academies Press (US); 2003.
West SL, Gassas A, Schechter T, et al. Exercise intolerance and the impact of physical activity in children treated with hematopoietic stem cell transplantation. Pediatr Exerc Sci. 2014;26:358–364.
Brussel M, van, Takken T, Net J van der, et al. Physical function and fitness in long-term survivors of childhood leukaemia. Pediatr Rehabil. 2009;9:267–274.
Warner JT, Bell W, Webb DKH, et al. Relationship between cardiopulmonary response to exercise and adiposity in survivors of childhood malignancy. Arch Dis Child. 1997;76:298.
Hauser M, Gibson BS, Wilson N. Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography. Eur J Pediatr. 2001;160:607–610.
Ness KK, Gurney JG. Adverse late effects of childhood cancer and its treatment on health and performance. Annu Rev Public Health. 2007;28:279–302.
Hartman A, Bos C, van den, Stijnen T, et al. Decrease in peripheral muscle strength and ankle dorsiflexion as long-term side effects of treatment for childhood cancer. Pediatr Blood Cancer. 2008;50:833–837.
Ness KK, Morris EB, Nolan VG, et al. Physical performance limitations among adult survivors of childhood brain tumors. Cancer. 2010;116:3034–3044.
Riggs L, Piscione J, Laughlin S, et al. Exercise training for neural recovery in a restricted sample of pediatric brain tumor survivors: a controlled clinical trial with crossover of training versus no training. Neuro Oncol. 2016;19:440–450.
Moyer-Mileur LJ, Ransdell L, Bruggers CS. Fitness of children with standard-risk acute lymphoblastic leukemia during maintenance therapy. J Pediatr Hematol Oncol. 2009;31:259–266.
Baumann FT, Bloch W, Beulertz J. Clinical exercise interventions in pediatric oncology: a systematic review. Pediatr Res. 2013;74:366–374.
Brussel M van, Takken T, Lucia A, et al. Is physical fitness decreased in survivors of childhood leukemia? A systematic review. Leukemia. 2005;19:13–17.
Mihlon F, Ray C, Messersmith W. Chemotherapy agents: a primer for the interventional radiologist. Semin Intervent Radiol. 2010;27:384–390.
Piña-Garza JE. Fenichel’s Clinical Pediatric Neurology (Seventh Edition). London, UK: Elsevier; 2013:195–206.
Inaba H, Pui C-H. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol. 2010;11:1096–1106.
Hanaoka BY, Peterson CA, Crofford LJ. Glucocorticoid effects on skeletal muscle: benefit and risk in patients with autoimmune inflammatory rheumatoid diseases. Expert Rev Clin Immunol. 2014;8:695–697.
Huang T-T, Ness KK. Exercise interventions in children with cancer: a review. Int J Pediatrics. 2011;2011:461512.
Wells GD, O’Gorman CS, Rayner T, et al. Skeletal muscle abnormalities in girls and adolescents with Turner syndrome. J Clin Endocrinol Metab. 2013;98:2521–2527.
West SL, White G, Caterini JE, et al. Skeletal muscle dysfunction and exercise intolerance in children treated with haematopoietic stem cell transplant—a pilot feasibility study. Int J Environ Res Public Health. 2019;16:1608.
Wells GD, Wilkes DL, Schneiderman JE, et al. Skeletal muscle metabolism in cystic fibrosis and primary ciliary dyskinesia. Pediatr Res. 2011;69:40–45.
Wells GD, Banks L, Caterini JE, et al. The association among skeletal muscle phosphocreatine recovery, adiposity, and insulin resistance in children. Pediatr Obes. 2017;12:163–170.
van Brussel M, van Oorschot JWM, Schmitz JPJ, et al. Muscle metabolic responses during dynamic in-magnet exercise testing a pilot study in children with an idiopathic inflammatory myopathy. Acad Radiol. 2015;22:1443–1448.
West SL, Banks L, Schneiderman JE, et al. Physical activity for children with chronic disease; a narrative review and practical applications. BMC Pediatr. 2019;19:12.
Breithaupt P, Adamo KB, Colley RC. The HALO submaximal treadmill protocol to measure cardiorespiratory fitness in obese children and youth: a proof of principle study. Appl Physiol Nutr Metab. 2012;37:308–314.
Nemeth BA, Carrel AL, Eickhoff J, et al. Submaximal treadmill test predicts V̇O 2max in overweight children. J Pediatr. 2009;154:677.e1–681.e1.
Hay JA, University B, Cairney J. Development of the habitual activity estimation scale for clinical research: a systematic approach. Pediatr Exerc Sci. 2006;18:193–202.
Wells GD, Wilkes DL, Schneiderman‐Walker J, et al. Reliability and validity of the Habitual Activity Estimation Scale (HAES) in patients with cystic fibrosis. Pediatr Pulmonol. 2008;43:345–353.
van de Velde ME, Kaspers GL, Abbink FCH, et al. Vincristine-induced peripheral neuropathy in children with cancer: a systematic review. Crit Rev Oncol Hematol. 2017;114:114–130.
Lanfranconi F, Zardo W, Moriggi T, et al. Precision-based exercise as a new therapeutic option for children and adolescents with haematological malignancies. Sci Rep. 2020;10:12892.
Hartman A, van den Bos C, Stijnen T, et al. Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine. Cancer. 2006;106:1395–1401.
Warner JT, Bell W, Webb DKH, et al. Daily energy expenditure and physical activity in survivors of childhood malignancy. Pediatr Res. 1998;43:607–613.
Ladha AB, Courneya KS, Bell GJ, et al. Effects of acute exercise on neutrophils in pediatric acute lymphoblastic leukemia survivors: a pilot study. J Pediatr Hematol Oncol. 2006;28:671–677.
Okada M, Meeske KA, Menteer J, et al. Exercise recommendations for childhood cancer survivors exposed to cardiotoxic therapies. J Pediatr Oncol Nurs. 2012;29:246–252.
Zhang FF, Parsons SK. Obesity in childhood cancer survivors: call for early weight management. Adv Nutr. 2015;6:611–619.
Maher JM, Markey JC, Ebert-May D. The other half of the story: effect size analysis in quantitative research. CBE Life Sci Educ. 2013;12:345–351.
Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: a practical primer for t-tests and ANOVAs. Front Psychol. 2013;4:863.